Tower Research Capital LLC (TRC) - PETROS PHARMACEUTICALS INC ownership

PETROS PHARMACEUTICALS INC's ticker is and the CUSIP is 71678J209. A total of 15 filers reported holding PETROS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PETROS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,398
-14.9%
2,542
-0.2%
0.00%
Q2 2023$5,168
+172166.7%
2,546
+10.2%
0.00%
Q1 2023$3
+200.0%
2,310
+359.2%
0.00%
Q4 2022$15030.00%
Other shareholders
PETROS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
EMFO, LLC 1,000$1,7300.00%
Newbridge Financial Services Group, Inc. 120$2080.00%
VANGUARD GROUP INC 31,811$55,0300.00%
Schonfeld Strategic Advisors LLC 22,700$39,2680.00%
OSAIC HOLDINGS, INC. 14$240.00%
BANK OF AMERICA CORP /DE/ 1$20.00%
FIRST MANHATTAN CO. LLC. 10$170.00%
WELLS FARGO & COMPANY/MN 11$190.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 79$1310.00%
View complete list of PETROS PHARMACEUTICALS INC shareholders